HomeCNSP • NASDAQ
CNS Pharmaceuticals Inc
add
$1.26
9.57%
After Hours:(4.75%)-0.060
$1.20
Closed: May 15, 5:14:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.20M | -40.51% |
Net income | -3.18M | 40.91% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.20M | 40.52% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.46M | 1,077.53% |
Total assets | 8.70M | 411.56% |
Total liabilities | 2.52M | -58.84% |
Total equity | 6.18M | — |
Shares outstanding | 2.94M | — |
Price to book | 0.26 | — |
Return on assets | -99.32% | — |
Return on capital | -161.84% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.18M | 40.91% |
Cash from operations | -5.47M | -115.70% |
Cash from investing | -4.19K | -94.16% |
Cash from financing | 4.96M | 127.92% |
Net change in cash | -511.75K | -41.83% |
Free cash flow | -6.08M | -399.54% |
Previous close
$1.15
Day range
$1.10 - $1.26
Year range
$0.77 - $800.00
Market cap
3.71M USD
Avg Volume
3.25M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
4
